Literature DB >> 18134519

Studies in Hodgkin's syndrome; the association of viral hepatitis and Hodgkin's disease; a preliminary report.

H A HOSTER, R P ZANES, E VON HAAM.   

Abstract

Entities:  

Keywords:  HEPATITIS/viral; HODGKIN'S DISEASE

Mesh:

Year:  1949        PMID: 18134519

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  31 in total

1.  [The oncolytic properties of viruses].

Authors:  R SIEGERT
Journal:  Arch Gesamte Virusforsch       Date:  1955

2.  ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN.

Authors:  J Carson; D Haddad; M Bressman; Y Fong
Journal:  Drugs Future       Date:  2010       Impact factor: 0.148

3.  A protective role for early oral exposures in the etiology of young adult Hodgkin lymphoma.

Authors:  Wendy Cozen; Ann S Hamilton; Peng Zhao; Muhammad T Salam; Dennis M Deapen; Bharat N Nathwani; Lawrence M Weiss; Thomas M Mack
Journal:  Blood       Date:  2009-09-08       Impact factor: 22.113

4.  Recombinant poliovirus for cancer immunotherapy.

Authors:  Millena Prata Jammal; Márcia Antoniazi Michelin; Rosekeila Simões Nomelini; Eddie Fernando Candido Murta
Journal:  Ann Transl Med       Date:  2018-09

Review 5.  Updates on immunotherapy for colorectal cancer.

Authors:  Aparna Kalyan; Sheetal Kircher; Hiral Shah; Mary Mulcahy; Al Benson
Journal:  J Gastrointest Oncol       Date:  2018-02

Review 6.  Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.

Authors:  Susanne G Carpenter; Joshua Carson; Yuman Fong
Journal:  Semin Oncol       Date:  2010-04       Impact factor: 4.929

Review 7.  Measles virus for cancer therapy.

Authors:  S J Russell; K W Peng
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

8.  Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?

Authors:  Mahua Dey; Brenda Auffinger; Maciej S Lesniak; Atique U Ahmed
Journal:  Future Virol       Date:  2013-07       Impact factor: 1.831

Review 9.  Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

Authors:  Roberto Cattaneo; Tanner Miest; Elena V Shashkova; Michael A Barry
Journal:  Nat Rev Microbiol       Date:  2008-07       Impact factor: 60.633

Review 10.  Oncolytic virotherapy for urological cancers.

Authors:  Zahid Delwar; Kaixin Zhang; Paul S Rennie; William Jia
Journal:  Nat Rev Urol       Date:  2016-05-24       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.